
Energy
SUNROAD
The main objective of the SUNROAD (Strategic Roadmap For a Solar Europe) project is the creation and implementation of a...
Project dates
2017-2021
Role of Zabala
partner
Project led by
IDIBAPS Y HOSPITAL CLÍNIC
14
Partners
6.7
M€ budget
37 M
People living with HIV
2 M
People contract HIV annually
IDIBAPS and Hospital Clínic are working on this European project that aims to change the current paradigm of HIV treatment by obtaining a functional cure. Although there are numerous prevention strategies that have given good results, they are difficult to maintain in the long term. Achieving a functional cure would leave patients carrying the virus at undetectable levels, and although prevention measures would still be necessary, the risk of transmission would be minimised. Zabala Innovation participates in the coordination and management of this project together with 13 other European organisations.
According to the World Health Organization (WHO), 37 million people in the world are living with HIV and there are more than 2 million new infections each year. Although there are numerous successful prevention strategies, they are difficult to sustain in the long term. A functional cure for HIV is one of the major challenges in the fight against HIV.
The HIVACAR project proposes as a strategy the administration of a combination of immunotherapy that includes therapeutic vaccines (one of them personalised for each patient to prevent the escape of the virus from the vaccine), a potent antibody with the capacity to neutralise the binding site of the virus with the cells it infects and a molecule capable of reversing the latency of the virus, i.e. to unmask it.
This will be done in the framework of a Phase II clinical trial, to test its safety and tolerability. It will be determined whether this combination can activate the immune system mechanisms necessary to eliminate the infected cells from the latent viral reservoir. The socioeconomic and psychosocial impact of this treatment will also be analysed. HIVACAR will improve the quality of life of patients, reduce the current costs of HIV treatment and help control HIV replication for long periods of time or for life, without antiretroviral treatment.
This project has been financed by the European Union’s Horizon 2020 Research and Innovation programme, under grant agreement No. 731626.
“Achieving a functional cure would make patients carriers of the virus at undetectable levels.”
Laura Sesma
Team leader expert in European Programmes in the Health Area
Energy
The main objective of the SUNROAD (Strategic Roadmap For a Solar Europe) project is the creation and implementation of a...
Digital
Data Market Services aims to overcome the barriers in the way of SMEs and data-driven start-ups to market success.
Energy
CIRCUSOL aims to promote the solar energy sector as a leading model in the circular economy.
News
RBDCOV PROJECT
The project, funded with 9 million euros by Horizon Europe, aims to test the HIPRA vaccine in paediatric and immunocompromised participants
Opinion
Cybersecurity
Natalia García-Barberena
Senior Consultant and cybersecurity expert
Publication
CITIES
Check out our downloadable document that summarises EU funding opportunities for urbans projects
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.